What is diabetic retinopathy?

 

Diabetic retinopathy is an eye condition that can lead to impairment of eyesight or even blindness in people with diabetes. For most diabetics, it is a matter of when not if they will develop retinopathy - it is also the leading cause of blindness in American adults.
Retinopathy affects small blood vessels in the retina, a light-sensitive layer of tissue on the back of the eye.

 

Often there are no early signs and some people might have 20/20 vision while others might have difficulty reading or seeing faraway objects - symptoms that could easily be attributed to “regular” and less dangerous problems of the eye.

This stage is called non-proliferative diabetic retinopathy (NDPR) and while the damage is not fully reversible it is manageable with proper treatment, preventing any significant loss of vision. 

Until recently, the only way to detect NDPR before any noticeable symptoms was through retinal examination by a trained ophthalmologist or optometrist.

The second stage, called proliferative diabetic retinopathy (NPR), is when damage to the blood vessels is significant enough to cause blurriness of vision, which can progress to only being able to tell light from dark. Management through treatment is, again, possible, but in most cases full vision can not be restored.

 
 

General symptoms to watch out for:

Blur in the center of vision

Straight lines that look curved

Blind spots or spots

Colors that look dull or washed out

 
 

Diabetic retinopathy can lead to other serious eye conditions: 

Diabetic macular edema (DME)
Over time, about 1 in 15 people with diabetes will develop DME. DME happens when blood vessels in the retina leak fluid into the macula (a part of the retina needed for sharp, central vision). This causes blurry vision.

Neovascular glaucoma
Diabetic retinopathy can cause abnormal blood vessels to grow out of the retina and block fluid from draining out of the eye. This causes a type of glaucoma (a group of eye diseases that can cause vision loss and blindness).

Retinal detachment
Diabetic retinopathy can cause scars to form in the back of your eye which can pull the retina away from the back of the eye.

 
 

Who is at risk?

Anyone with any kind of diabetes, including gestational diabetes (which can occur during pregnancy) can get diabetic retinopathy.

Risk factors:

  • Having diabetes for a long time

  • Poor control blood sugar level

  • High blood pressure

  • High cholesterol

  • Pregnancy

  • Tobacco use

  • Black, Hispanic or Native Americans are at higher risk

 
 

Prevention and treatment

Diabetes causes high blood sugar which damages all blood vessels, including ones in the retina, so good management of diabetes can lower the overall risk of diabetic retinopathy. This means regular physical activity, eating healthy, monitoring blood sugar levels and regularly taking medication as prescribed. 

In case of early detection and if there had not yet been any signs of vision degradation, regular dilated eye exams (every 2 to 4 months) are all that might be necessary. In later stages, and especially if vision degradation had already occured, treatment should start right away in order to halt further damage. Treatment can consist of:

Anti-VEGF drugs
Damage to small blood vessels of the retina is partly caused by overproduction of a protein called vascular endothelial growth factor (VEGF). Anti-VEGF drugs are injected into the eye to block the harmful effects of this protein.

Corticosteroids
Corticosteroids also combat VEGF by reducing its production as well as reduce occurrence of Diabetic macular edema (DME)

Laser treatment
Scatter laser surgery is used to reduce growth of new abnormal blood vessels as well as treat existing damaged ones

Eye surgery
Vitrectomy can be used to remove accumulated blood in the middle of the eye as well as deal with scar tissue in more advanced stages of diabetic retinopathy

 

There is however currently no cure or ways to fully reverse existing damage. The only path to preventing diabetic retinopathy complication is through early detection by regular screening, ideally at least once a year. This is easier said than done as often the biggest hurdle is lack of awareness among diabetics. In some parts of the world, this is compounded by lack of equipment as well as personnel able to conduct screening in sufficient numbers.

 
 

The total number of individuals worldwide with diabetes is expected to increase from 387 million to 592 million people in 2035.
Worldwide prevalence of DR in patients with type 1 DM is 77.3% and with type 2 is 25.1%.

Changes in diet and lifestyle are suspected in the increase in DR prevalence.

https://www.aao.org/topic-detail/diabetic-retinopathy-latin-america

 

How Vitazi.ai can help

Technology can change everything and we believe that in this case it could tackle both lack of awareness as well as lack of infrastructure. If a screening could be done in minutes as part of a regular checkup or even a visit to a pharmacy, awareness stops being such an issue. Going further, this could enable establishment of entirely new, systemic screening programs.

 
 

The last point is our main hope for what Vitazi-DR could be used for, as systemic screening is by far the most effective way of battling diabetic retinopathy. 

Our work up to this point has been focused on Mexico, where diabetic retinopathy is the number one cause of adult blindness. This also used to be the case in the UK, the largest country to implement a systemic screening approach. The programme started in 2003, reaching national coverage in 2008, covering more than 80% of diabetics - more than 2,250,00 from 2016 to 2017 alone. 

In 2010, for the first time in 50 years, diabetic retinopathy was no longer the main cause of adult blindness in the UK (https://www.dovepress.com/the-evolution-of-diabetic-retinopathy-screening-programmes-a-chronolog-peer-reviewed-fulltext-article-OPTH#CIT0019).